Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
gianluca.rampionivinciguerra@uniroma1.it
Gian Luca Rampioni Vinciguerra
Ricercatore
Struttura:
DIPARTIMENTO DI MEDICINA CLINICA E MOLECOLARE
E-mail:
gianluca.rampionivinciguerra@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
miR-1297 is frequently downmodulated in flat epithelial atypia of the breast and promotes mammary neoplastic transformation via EphrinA2 regulation
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
2025
Loss of the extracellular matrix glycoprotein EMILIN1 accelerates Δ16HER2-driven breast cancer initiation in mice
NPJ BREAST CANCER
2024
Nutrient restriction-activated Fra-2 promotes tumor progression via IGF1R in miR-15a downmodulated pancreatic ductal adenocarcinoma
SIGNAL TRANSDUCTION AND TARGETED THERAPY
2024
Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancer
EMBO MOLECULAR MEDICINE
2024
A comprehensive luminal breast cancer patient-derived xenografts (PDX) library to capture tumor heterogeneity and explore the mechanisms of resistance to CDK4/6 inhibitors
JOURNAL OF PATHOLOGY
2024
Editorial: catch me if you can: cellular plasticity in tumor progression and drug resistance
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
2024
USP1 deubiquitinates PARP1 to regulate its trapping and PARylation activity
SCIENCE ADVANCES
2024
Role of the miR-301a/Fra-2/GLIPR1 axis in lung cancer cisplatin resistance
SIGNAL TRANSDUCTION AND TARGETED THERAPY
2023
Clear cell carcinoma of the stomach: a rare tumor variant imparting poor prognosis
ACTA CHIRURGICA BELGICA
2023
Loss of CDKN1B induces an age‐related clonal hematopoietic disorder via Notch2 activity dysregulation
CANCER COMMUNICATIONS
2023
A novel auxin-inducible degron system for rapid, cell cycle-specific targeted proteolysis
CELL DEATH AND DIFFERENTIATION
2023
Role of Fra-2 in cancer
CELL DEATH AND DIFFERENTIATION
2023
CDK4/6 Inhibitors in Combination Therapies: Better in Company Than Alone: A Mini Review
FRONTIERS IN ONCOLOGY
2022
EMILIN-1 deficiency promotes chronic inflammatory disease through TGFβ signaling alteration and impairment of the gC1q/α4β1 integrin interaction
MATRIX BIOLOGY
2022
Pan-Cancer Analysis of Canonical and Modified miRNAs Enhances the Resolution of the Functional miRNAome in Cancer
CANCER RESEARCH
2022
CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer
JOURNAL OF PATHOLOGY
2021
miR-9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCC
EMBO MOLECULAR MEDICINE
2021
p27kip1 expression and phosphorylation dictate Palbociclib sensitivity in KRAS-mutated colorectal cancer
CELL DEATH & DISEASE
2021
Evaluation of Angiogenesis-Related Genes as Prognostic Biomarkers of Bevacizumab Treated Ovarian Cancer Patients. Results from the Phase IV MITO16A/ManGO OV-2 Translational Study
CANCERS
2021
Downregulation of miR-223 expression is an early event during mammary transformation and confers resistance to CDK4/6 inhibitors in luminal breast cancer
CANCER RESEARCH
2020
1
2
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma